当前位置: 首页 >> 检索结果
81. Effect of plasma adsorption and low-volume plasma exchange on intracranial pressure in acute-on-chronic liver failure: a prospective observational study.
作者: Yuanji Ma.;Ziyan Li.;Yan Xu.;Shaoqun Zhou.;Qi Yang.;Lingyao Du.;Fang Chen.;Lang Bai.;Hong Tang.
来源: BMC Gastroenterol. 2025年25卷1期545页
Patients with liver failure may be accompanied by cerebral edema and elevated intracranial pressure (ICP). The effect of plasma adsorption (PA) and low-volume plasma exchange (PE) on ICP were unclear.
82. Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank.
作者: Qi Feng.;Chioma N Izzi-Engbeaya.;Pinelopi Manousou.;Mark Woodward.
来源: BMC Gastroenterol. 2025年25卷1期546页
People with metabolic-dysfunction associated steatotic liver disease (MASLD) had higher risk of extrahepatic multimorbidity, and fibrosis is the strongest prognostic factor for mortality in MASLD. This study aimed to investigate how fibrosis was associated with multimorbidity and their relationships with all-cause mortality.
83. METS-VF as a novel predictor of gallstones in U.S. adults: a cross-sectional analysis (NHANES 2017-2020).
作者: Hui Wang.;Longlong Li.;Yi Yang.;Siyu Tao.;Yuan Li.;Hangyu Li.;Heshan Chen.;Ping Wu.
来源: BMC Gastroenterol. 2025年25卷1期547页
Obesity is a well-established risk factor for gallstone formation, but traditional anthropometric measures (e.g., BMI, waist circumference) inadequately assess metabolically active visceral adiposity. The novel Metabolic Score for Visceral Fat (METS-VF) may better capture obesity-related metabolic dysfunction. We aimed to investigate the association between METS-VF and gallstone prevalence and compare its predictive performance against conventional obesity indices (WC, LAP, VAI) in a U.S. national cohort.
85. Risk factors and clinical characteristics of occult pancreaticobiliary reflux in benign gallbladder diseases.
作者: Yukai Xiang.;Chen Qiu.;Hai Hu.;Jingli Cai.;Gang Zhao.;Anhua Huang.;Anan Xu.;Chuanqi He.;Cheng Zhang.;Yulong Yang.;Zhaoyan Jiang.
来源: BMC Gastroenterol. 2025年25卷1期542页
This study aimed to elucidate the clinical characteristics of occult pancreaticobiliary reflux (OPBR) in benign gallbladder diseases, including gallbladder stone (GS), gallbladder polyp (GP), and gallbladder adenomyomatosis (GA).
86. Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.
作者: Wenhui Ren.;Zilong Wang.;Xinyue Liu.;Xin Liu.;Danli Ma.;Qian Jin.;Jian Wang.;Jiajun Feng.;Huiying Rao.;Xiaoxiao Wang.;Rui Huang.
来源: BMC Gastroenterol. 2025年25卷1期541页
The purpose of this study was to evaluate how nonalcoholic fatty liver disease (NAFLD) impacts the progression and prognosis of primary biliary cholangitis (PBC).
87. The relationships between symptom clusters and contributing factors in patients with esophageal cancer: structural equation modelling based on theory of unpleasant symptoms.
作者: Xiuqin Ren.;Aijuan Wang.;Xiaowei Wei.;Ying Yu.;Xiancui Wu.;Suping Qin.
来源: BMC Gastroenterol. 2025年25卷1期544页
The caring behaviors of nurses play a crucial role in improving the quality of care in hospitals. This study aimed to investigate the symptom clusters of patients with esophageal cancer undergoing radiotherapy or chemoradiotherapy, as well as the relationship among symptom clusters, NLR (neutrophil to lymphocyte ratio), ALB (albumin), anxiety, depression, social support, self-care, and self-efficacy through structural equation modeling based on the theory of unpleasant symptoms (TOUS).
88. Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study/study of Latinos (HCHS/SOL), a population-based cohort study.
作者: Mario Jesus Trejo.;James S Floyd.;Daniele Massera.;Martha Daviglus.;Olga Garcia-Bedoya.;Jianwen Cai.;Gregory A Talavera.;Dorathy E Tamayo-Murillo.;Daniel Labovitz.;Robert Kaplan.
来源: BMC Gastroenterol. 2025年25卷1期543页
Metabolic dysfunction-associated steatotic liver disease (MASLD) increases risk of cardiovascular disease (CVD). Despite the high prevalence of MASLD among Hispanic populations, there is a scarcity of research on the associations between non-invasive markers of liver disease and incident CVD and all-cause mortality. In this study we investigated the association of liver related biomarkers with CVD events and all-cause mortality in a population based Hispanic/Latino cohort.
89. Building a risk prediction model for anastomotic leakage postoperative low rectal cancer based on Lasso-Logistic regression.
作者: Zhenhao Quan.;Lin Lin.;Renwei Huang.;Kaiyu Sun.;Feipeng Xu.
来源: BMC Gastroenterol. 2025年25卷1期540页
To build a nomogram model for predicting the risk of anastomotic leakage (AL) postoperative low rectal cancer based on Lasso-Logistic regression.
90. Association of red blood cell distribution width with short- and long-term all-cause mortality in patients with acute pancreatitis and sepsis.
作者: Qingzhou Song.;Xuanlin Wu.;Firooz Ahmad Taheri.;Linghou Meng.;Wentao Wang.;Xianwei Mo.
来源: BMC Gastroenterol. 2025年25卷1期539页
The association between red blood cell distribution width (RDW) and short- and long-term all-cause mortality in patients with acute pancreatitis (AP) and sepsis remains unclear.
91. Unraveling the link between inflammatory bowel disease and perianal abscess: insights from bidirectional and multivariable Mendelian randomization study.
Emerging epidemiological studies have identified associations between perianal abscess (PA) and inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), though the pathophysiological mechanisms underlying their comorbidity remain incompletely understood. To elucidate potential causal relationships between these clinical entities, we conducted a comprehensive investigation employing bidirectional two-sample Mendelian randomization (MR) analysis complemented by multivariable Mendelian randomization (MVMR) methodology. This analytical approach enables systematic evaluation of causal directionality while accounting for potential confounding factors inherent in observational studies.
92. Cardiometabolic Index as a predictor of mortality in metabolic Dysfunction-Associated Steatotic Liver Disease.
作者: Yang Yang.;Cheng Zeng.;Zhiqiang Jin.;Yi Huang.;Huabao Liu.
来源: BMC Gastroenterol. 2025年25卷1期537页
Cardiometabolic Index (CMI) is positively correlated with liver fibrosis in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), but its association with mortality risk in MASLD patients remains unclear.
93. Correlation between systemic inflammatory response syndrome and prognosis of patients with cirrhosis and hepatic encephalopathy.
作者: Kaiyue Zhang.;Ziqun Qu.;Rongyu Tang.;Hongliang Dong.;Jing Fan.;Wei Ye.
来源: BMC Gastroenterol. 2025年25卷1期536页
Although systemic inflammatory response syndrome (SIRS) is associated with the progression of cirrhosis, its clinical significance in patients with cirrhosis and hepatic encephalopathy (HE) remains unclear.
94. Management and outcomes of patients with obstructive jaundice from pancreatobiliary diseases in Rwanda.
作者: Zainab Ingabire.;Aberra B Hanna.;Emile Sebera.;Janvier Murayire.;Gamal S Mohamed.;Eric Rutaganda.;Felicien Shikama.;Marie Solange Mukanumviye.;Dyna Nyampinga.;Innocenti Dadamessi.;Kulwinder Dua.;Redae Berhane.
来源: BMC Gastroenterol. 2025年25卷1期535页
Obstructive jaundice from pancreatobiliary diseases represents a significant global health challenge, particularly in resource-limited settings like Rwanda. While endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) are now available at tertiary centers in Kigali, there is limited local clinical data on the management and outcomes of these conditions. This study aims to assess the patterns, therapeutic approaches, and outcomes of obstructive jaundice in the Rwandan healthcare context.
95. Analysis of influencing factors and nursing strategies for enteral nutrition patients complicated with refeeding syndrome in ICU.
To analyze the influencing factors and nursing strategies for enteral nutrition patients complicated with refeeding syndrome (RS) in the ICU.
96. LINC00634 is a novel prognostic biomarker for colon cancer associated with immune infiltration.
作者: Haiyan Wang.;Yanyan Huang.;Lina Zhou.;Xiaotong Zhu.;Xuan Ye.;Yi Cen.
来源: BMC Gastroenterol. 2025年25卷1期533页
Colon cancer is a highly heterogeneous and most common malignant tumor of the gastrointestinal tract, which is prone to metastasis in advanced stages, leading to a poor prognosis for patients.
97. Efficacy and safety of vedolizumab in elderly and younger patients with moderate-to-severe ulcerative colitis: a retrospective real-world study in China.
作者: Hao Zhang.;Xue-Li Ding.;Yong-Hong Xu.;Jun Wu.;Yue-Yuan Wang.;Shu-Xian Liu.;Jing Yan.;Hua Liu.;Zi-Bin Tian.;Ai-Ling Liu.
来源: BMC Gastroenterol. 2025年25卷1期531页
Limited data exist regarding the efficacy and safety of vedolizumab (VDZ) in China's elderly adult population with ulcerative colitis (UC) in China. In this investigation, a comparative analysis of its efficacy and safety was performed between elderly and younger adult UC cohorts.
98. Development and validation of a nomogram-based risk prediction model for non-alcoholic fatty liver disease (NAFLD): a logistic regression analysis in a physical examination population.
The global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached an alarming 25%, based on recent population-based studies. NAFLD diagnosis primarily relies on imaging methods, which may be invasive, costly, or limited. Existing prediction models, such as the Fatty Liver Index (FLI) and NAFLD Liver Fat Score (NLFS), mainly incorporate metabolic parameters from Western populations and neglect non-metabolic factors, limiting their generalizability. To address these limitations, this study developed a screening model integrating both metabolic and non-metabolic indicators, tailored specifically to diverse populations undergoing routine physical examinations.
99. Correction: Accuracy of the diagnosis of gastroesophageal reflux disease by a trial of potassium-competitive acid blocker treatment.
作者: Peiwen Dong.;Lin Lin.;Kaidi Sun.;Feng Tang.;Qian Li.;Xinxu Zhou.;Fuli Liu.;Zhilin Yang.;Jiao Li.;Lin Jiang.;Ping Zhao.;Xiaobin Sun.;Qiong Wang.
来源: BMC Gastroenterol. 2025年25卷1期530页 |